Company facts
- Industry
- Pharmaceutical Preparations
- Headquarters
- Indianapolis, Indiana
- Most recent report
- 10-Q, filed Aug 5, 2026
- Incorporated
- Indiana
- Filings on record
- 1,005+ filings
- On EDGAR
- CIK 59478
- Fiscal year ends
- December
- Filer status
- Large accelerated filer
Financials 8 of 19
News 8 of 45
Prospectuses and Registrations 8 of 23
- 25-NSE Notice that a security was delisted Jun 2, 2026
- 424B2 Prospectus supplement for an offering May 8, 2026
- FWP Free writing prospectus May 6, 2026
- 424B2 Prospectus supplement for an offering May 6, 2026
- 424B2 Prospectus supplement for an offering Aug 19, 2025
- FWP Free writing prospectus Aug 18, 2025
- 424B2 Prospectus supplement for an offering Aug 18, 2025
- 25-NSE Notice that a security was delisted Jun 2, 2025
Proxies 8 of 32
- PX14A6G Shareholder's own proxy material Apr 29, 2026
- DEFA14A Extra proxy material Mar 20, 2026
- DEF 14A Proxy statement for a shareholder vote Mar 20, 2026
- PRE 14A Preliminary proxy statement Mar 6, 2026
- PX14A6G Shareholder's own proxy material Mar 31, 2025
- DEFA14A Extra proxy material Mar 21, 2025
- DEF 14A Proxy statement for a shareholder vote Mar 21, 2025
- PRE 14A Preliminary proxy statement Mar 7, 2025
Ownership 8 of 825
- 4 Insider reported a trade Aug 18, 2026
- 4 Insider reported a trade Aug 18, 2026
- 4 Insider reported a trade Aug 18, 2026
- 4 Insider reported a trade Aug 18, 2026
- 4 Insider reported a trade Aug 18, 2026
- 144 Notice of a proposed sale of restricted stock Aug 17, 2026
- 4 Insider reported a trade Aug 11, 2026
- 144 Notice of a proposed sale of restricted stock Aug 10, 2026
Other 8 of 61
Everything here comes from ELI LILLY & Co's own filings on SEC EDGAR. The filing list is rechecked every hour.